![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Hikma Pharmaceuticals Plc 29 July 2024 Hikma Pharmaceuticals PLC Director Declaration LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14, Hikma Pharmaceuticals PLC confirms that Victoria...
Hikma Pharmaceuticals Plc 15 July 2024 London, 15 July 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial results for the six months ended 30 June 2024 on...
Hikma Pharmaceuticals Plc 01 July 2024 Hikma Pharmaceuticals PLC (the Company) Total Voting Rights and Capital LONDON, 1 July 2024 - In accordance with section 5.6.1 of the UK Financial...
Hikma Pharmaceuticals Plc 27 June 2024 Hikma Pharmaceuticals PLC Director Declaration In accordance with Listing Rule 9.6.14, Hikma Pharmaceuticals PLC announces that Victoria Hull, Senior...
Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmar ...
Hikma Pharmaceuticals Plc 17 June 2024 Hikma acquires Xellia's differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D London, 17 June 2024...
Shares in Hikma Pharmaceuticals PLC rose on Tuesday as analysts at Citi increased the bank's net present value price ...
Hikma Pharmaceuticals Plc 05 June 2024 Hikma Pharmaceuticals PLC Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions